Merck & Co., Inc., known as MSD outside the United States and Canada, is a leading global healthcare company headquartered in Rahway, New Jersey. Founded in 1891, Merck has established itself as a pioneer in the pharmaceutical industry, focusing on innovative medicines, vaccines, and animal health products. With a strong presence in North America, Europe, and emerging markets, Merck is renowned for its commitment to research and development, resulting in groundbreaking therapies in areas such as oncology, infectious diseases, and diabetes management. Notable products include the HPV vaccine Gardasil and the cancer treatment Keytruda, both of which have significantly impacted public health. Merck's dedication to scientific excellence and patient care has solidified its position as a trusted leader in the pharmaceutical sector, consistently achieving recognition for its contributions to global health.
How does Merck And Co Inc Rahway Nj Usa Which Is Known As Msd Outside Us And Canada's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Merck And Co Inc Rahway Nj Usa Which Is Known As Msd Outside Us And Canada's score of 55 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Merck & Co., Inc. (known as MSD outside the US and Canada) reported total carbon emissions of approximately 7,086,700,000 kg CO2e. This figure includes Scope 1 emissions of about 718,400,000 kg CO2e, Scope 2 emissions of approximately 184,200,000 kg CO2e (market-based), and Scope 3 emissions totalling around 6,184,100,000 kg CO2e. Merck has set ambitious climate commitments, aiming for net-zero greenhouse gas (GHG) emissions across all scopes (1, 2, and 3) by 2045. This target aligns with the Science Based Targets initiative (SBTi) guidelines. Additionally, the company plans to reduce its operational GHG emissions (Scopes 1 and 2) by 46% by 2030, using 2019 as a baseline. For its value chain emissions (Scope 3), Merck aims for a 30% reduction by 2030, also from a 2019 baseline. These initiatives reflect Merck's commitment to sustainability and its proactive approach to addressing climate change within the pharmaceutical industry.
Access structured emissions data, company-specific emission factors, and source documents
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 1,532,400,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 1,532,400,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | 5,760,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Merck And Co Inc Rahway Nj Usa Which Is Known As Msd Outside Us And Canada is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.